UBS AM’s NEOPHOTONICS CORP NPTN Stock Holding History

UBS AM’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43,178	Closed	-$679K	–	2800
2022 Q2	$679K	Sell	43,178 -1,294	-3%	-$19.8K	﹤0.01%	2161
2022 Q1	$676K	Sell	44,472 -20,166	-31%	-$307K	﹤0.01%	2341
2021 Q4	$993K	Hold	64,638	–	–	﹤0.01%	2214
2021 Q3	$563K	Hold	64,638	–	–	﹤0.01%	2455
2021 Q2	$660K	Buy	64,638 +4,150	+7%	+$43.8K	﹤0.01%	2420
2021 Q1	$723K	Buy	60,488 +388	+0.6%	+$4.4K	﹤0.01%	2233
2020 Q4	$546K	Buy	60,100 +2,900	+5%	+$22.4K	﹤0.01%	2273
2020 Q3	$348K	Buy	57,200 +500	+0.9%	+$3.82K	﹤0.01%	2272
2020 Q2	$503K	Buy	+56,700	New	+$489K	﹤0.01%	2129
2017 Q4	–	Sell	-10,800	Closed	-$60K	–	2614
2017 Q3	$60K	Hold	10,800	–	–	﹤0.01%	2386
2017 Q2	$83.4K	Hold	10,800	–	–	﹤0.01%	2359
2017 Q1	$97.3K	Hold	10,800	–	–	﹤0.01%	2302
2016 Q4	$117K	Sell	10,800 -20,100	-65%	-$268K	﹤0.01%	2226
2016 Q3	$505K	Buy	+30,900	New	+$435K	﹤0.01%	1975

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

UBS AM's NPTN Position: Q3 2022 in Review

UBS AM sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 43,178 shares — an estimated $679K sold.

UBS AM first reported a position in NPTN in Q3 2016 and held it in 14 quarters. The position peaked at $993K in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

UBS AM reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
UBS AM sold 43,178 NEOPHOTONICS CORP shares in Q3 2022, an estimated $679K.
UBS AM first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 14 quarters.
UBS AM's NEOPHOTONICS CORP position peaked at $993K in Q4 2021.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.